This stack targets the neurotransmitter systems and brain pathways responsible for clear thinking, fast recall, and sharper focuswithout the crash
The guide section on this site is particularly useful for beginners
Triple Receptor Mechanism Retatrutide is the first molecule to simultaneously engage all three receptors implicated in energy balance and body weight regulation: GLP-1 receptor: Reduces appetite, slows gastric emptying, improves glycemic control the same pathway as semaglutide (Ozempic/Wegovy) GIP receptor: Enhances insulin secretion and may contribute to fat mobilization the same dual pathway as tirzepatide (Mounjaro/Zepbound) Glucagon receptor: Increases energy expenditure, promotes hepatic fat oxidation, and drives thermogenesis a pathway unique to retatrutide among obesity therapeutics Clinical Significance In the Phase 2 trial published in the New England Journal of Medicine (2023), participants receiving the highest dose of retatrutide achieved a mean body weight reduction of 24.2% at 48 weeks with some participants losing over 30% of their body weight

Key Facts & Research Milestones: GHK-Cu Timeline GHK-Cu in the Context of Broader Longevity Research GHK-Cu does not exist in isolation within the peptide research landscape
This simple guide breaks down what BPC-157, TB-500, and GHK-Cu actually do, why people combine them, and what results many biohackers are chasing